ConductScience.org, home
Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis
API referenceFor AI assistants

Trial · NCT01194219

Participant flow160

How many started, completed or left each group, period by period.

1 to 20 of 160

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Placebo-Controlled Phase Weeks 0-16STARTEDApremilast562
Placebo-Controlled Phase Weeks 0-16STARTEDPlacebo282
Placebo-Controlled Phase Weeks 0-16STARTEDApremilast-Apremilast0
Placebo-Controlled Phase Weeks 0-16STARTEDPlacebo-Apremilast0
Placebo-Controlled Phase Weeks 0-16STARTEDAPR-APR-Re-randomized to PBO0
Placebo-Controlled Phase Weeks 0-16STARTEDAPR-APR-Re-randomized to APR0
Placebo-Controlled Phase Weeks 0-16STARTEDAPR-APR-APR + Optional Topicals/UVB0
Placebo-Controlled Phase Weeks 0-16STARTEDPBO-APR-APR + Optional Topicals/ UVB0
Placebo-Controlled Phase Weeks 0-16STARTEDApremilast (Long-term Extension)0
Placebo-Controlled Phase Weeks 0-16STARTEDPlacebo-Apremilast (Long-term Extension)0
Placebo-Controlled Phase Weeks 0-16Received ApremilastApremilast560
Placebo-Controlled Phase Weeks 0-16Received ApremilastPlacebo282
Placebo-Controlled Phase Weeks 0-16Received ApremilastApremilast-Apremilast0
Placebo-Controlled Phase Weeks 0-16Received ApremilastPlacebo-Apremilast0
Placebo-Controlled Phase Weeks 0-16Received ApremilastAPR-APR-Re-randomized to PBO0
Placebo-Controlled Phase Weeks 0-16Received ApremilastAPR-APR-Re-randomized to APR0
Placebo-Controlled Phase Weeks 0-16Received ApremilastAPR-APR-APR + Optional Topicals/UVB0
Placebo-Controlled Phase Weeks 0-16Received ApremilastPBO-APR-APR + Optional Topicals/ UVB0
Placebo-Controlled Phase Weeks 0-16Received ApremilastApremilast (Long-term Extension)0
Placebo-Controlled Phase Weeks 0-16Received ApremilastPlacebo-Apremilast (Long-term Extension)0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01194219/flow

API referenceFor AI assistants